Page 33 - Christiana Care Focus August 2018
P. 33

| Pharmacy Services
  Formulary Update | May 2018
Medication – Generic/Brand Name
Acetaminophen suppository/Tylenol
Beclomethasone dipropionate breath- activated oral inhaler/Qvar Redihaler
Benralizumab injection/ Fasenra
Heparin flush injection, preservative-free
Inotuzumab ozogamicin injection/ Besponsa
Ketorolac ophthalmic solution
Levalbuterol solution for nebulization
Lutetium Lu 177 dotatate injection/ Lutathera
Proparacaine/Fluorescein ophthalmic solution
Strength/Size
80 mg
40 mcg/actuation 10.6 gm inhaler
30 mg/mL prefilled syringe
10 units/mL 1 mL vial
0.9 mg vial
0.5%
5 mL bottle
1.25 mg/0.5 mL vial
200 mCi vial
0.5%/0.25% bottle
Use/Indication
Analgesic and antipyretic
Treatment of asthma
Add-on maintenance treatment of asthma with eosinophilic phenotype
Maintenance of IV line patency
Treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia in adults
Treatment of postoperative ocular inflammation
Treatment of bronchospasm
Treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors
Used in ophthalmic procedures when a topical disclosing agent is needed along with an anesthetic
Comment
Line item extension
Replaces inhaler containing aerosol solution
Administration limited to outpatient Christiana Care office practices
• Use limited to FDA-approved indications
• Prescribing limited to hematologists & oncologists
Alternative to diclofenac ophthalmic solution during shortage
• Available only in Nuclear Medicine Department
• Prescribing limited to nuclear medicine physicians and oncologists
                 Beclomethasone dipropionate aerosol solution inhaler/Qvar Edrophonium chloride injection
Neomycin/Polymyxin B solution for irrigation Neomycin/Polymyxin B cream
Product discontinued. Replaced with the breath-activated oral inhaler Product discontinued
Product discontinued
Product removed from formulary because of lack of use
             Levalbuterol Prescribing is no longer limited to pulmonologists Reslizumab injection/Cinqair
   FOCUS • AUGUST 2018 31
ADDITIONS DELETIONS
MEDICATION POLICY CHANGE
NOT ADDED TO FORMULARY















































   31   32   33   34   35